3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Colonic Neoplasms
3
Breast Neoplasms
3
Rectal Neoplasms
2
Leukemia, Myeloid, Acute
2
Colorectal Neoplasms
2
Vitamin D Deficiency
1
Renal Insufficiency, Chronic
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Osteoporosis
1
Obesity
1
Neurofibromatosis 1
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Musculoskeletal Diseases
1
Melanoma
1
Locally Advanced Breast Cancer and Large Operable Breast Cancer
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia, B-Cell
1
Leukemia
1
Healthy, no Evidence of Disease
1
Congenital Abnormalities
1
Cardiovascular Diseases
1
Interventions
ofatumumab
3
Vincristine
2
Rituximab
2
Lenalidomide
2
Bortezomib
2
tenofovir alafenamide
1
pomalidomide
1
pivalyloxymethyl butyrate
1
pegaspargase
1
nelarabine
1
immunotoxin HA22
1
fludarabine
1
bempegaldesleukin
1
Whole-Body Irradiation
1
Tablets
1
Panobinostat
1
Observation
1
Nivolumab
1
Mitoxantrone
1
Methotrexate
1
Mercaptopurine
1
Everolimus
1
Etoposide
1
Drug Therapy
1
Dexamethasone
1
DTRMWXHS-12
1
Cytarabine
1
Cyclophosphamide
1
Clofarabine
1
Cladribine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Leukemia, B-Cell
×
Cholecalciferol
×
Clear all
NCT01518959
2020-07-16
D-HEM
Semmelweis University
Phase 3
Terminated
31 enrolled